Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
101.21
-2.61 (-2.51%)
At close: Apr 24, 2026

SHA:688198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
663.57620.15500.26369.91295.07251.8
Other Revenue
--1.610.730.10.02
663.57620.15501.88370.64295.17251.82
Revenue Growth (YoY)
26.21%23.57%35.41%25.57%17.21%38.42%
Cost of Revenue
69.7867.0958.5237.6431.3629.61
Gross Profit
593.79553.06443.35333263.81222.21
Selling, General & Admin
218.96202.29154.92131.97123.77131.16
Research & Development
150.46155.33151.4498.8155.1558.9
Other Operating Expenses
3.02-10.363.461.251.621.17
Operating Expenses
372.44347.26312.22233.5181.64192.04
Operating Income
221.35205.8131.1499.582.1730.17
Interest Expense
---0.46-0.41-0.08-0.12
Interest & Investment Income
7.277.8517.3217.6622.5316.49
Currency Exchange Gain (Loss)
--0.05-0.260-
Other Non Operating Income (Expenses)
-8.37-8.35-0.16-0.06-0.68-0.05
EBT Excluding Unusual Items
220.25205.3147.89116.43103.9446.5
Gain (Loss) on Sale of Investments
0.720.830.7410.890.97
Gain (Loss) on Sale of Assets
0.010-0.050.05-0.01-0.02
Other Unusual Items
--2.22.541.322.31
Pretax Income
220.98206.13150.79120.02106.1449.76
Income Tax Expense
28.126.4518.6410.6111.74-1.51
Earnings From Continuing Operations
192.88179.68132.14109.4194.3951.26
Minority Interest in Earnings
9.5613.8914.195.80.73-0.06
Net Income
202.44193.57146.33115.2195.1351.2
Net Income to Common
202.44193.57146.33115.2195.1351.2
Net Income Growth
18.72%32.28%27.02%21.11%85.80%-9.42%
Shares Outstanding (Basic)
138137137136136135
Shares Outstanding (Diluted)
138137137137136135
Shares Change (YoY)
1.44%0.39%-0.29%0.92%0.86%0.44%
EPS (Basic)
1.471.411.070.850.700.38
EPS (Diluted)
1.471.411.070.840.700.38
EPS Growth
17.04%31.78%27.38%20.00%84.21%-9.82%
Free Cash Flow
55.2661.6-27.0212.5324.014.27
Free Cash Flow Per Share
0.400.45-0.200.090.180.03
Dividend Per Share
--0.8000.8000.5000.357
Dividend Growth
---60.00%40.02%149.90%
Gross Margin
89.48%89.18%88.34%89.84%89.38%88.24%
Operating Margin
33.36%33.19%26.13%26.85%27.84%11.98%
Profit Margin
30.51%31.21%29.16%31.08%32.23%20.33%
Free Cash Flow Margin
8.33%9.93%-5.38%3.38%8.14%1.70%
EBITDA
264.19243.94150.45110.787.7836.19
EBITDA Margin
39.81%39.34%29.98%29.87%29.74%14.37%
D&A For EBITDA
42.8438.1419.3111.195.616.02
EBIT
221.35205.8131.1499.582.1730.17
EBIT Margin
33.36%33.19%26.13%26.85%27.84%11.98%
Effective Tax Rate
12.72%12.83%12.36%8.84%11.06%-
Revenue as Reported
--501.88370.64295.17251.82
Advertising Expenses
--2.010.371.121.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.